• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国大型综合医疗机构中女性复发性尿路感染的危险因素。

Risk Factors for Recurrent Urinary Tract Infections Among Women in a Large Integrated Health Care Organization in the United States.

机构信息

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.

GlaxoSmithKline, Siena, Italy.

出版信息

J Infect Dis. 2024 Nov 15;230(5):e1101-e1111. doi: 10.1093/infdis/jiae331.

DOI:10.1093/infdis/jiae331
PMID:38941351
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11566237/
Abstract

BACKGROUND

Urinary tract infections (UTIs) occur commonly and often recur. However, recent data on the epidemiology of recurrent UTI (rUTI) are scarce.

METHODS

Between 1 January 2016 and 31 December 2020, index uncomplicated UTIs (uUTIs) from office, emergency department, hospital, and virtual care settings were identified from the electronic health records of women at Kaiser Permanente Southern California. We defined rUTI as ≥3 UTIs within 365 days or ≥2 UTIs within 180 days. We determined the proportion of women with cystitis index uUTI who had rUTI, and we examined factors associated with rUTIs using modified multivariable Poisson regression.

RESULTS

Among 374 171 women with cystitis index uUTI, 54 318 (14.5%) had rUTI. A higher proportion of women with rUTI vs those without rUTI were aged 18 to 27 or ≥78 years at index uUTI (19.7% vs 18.7% and 9.0% vs 6.0%, respectively), were immunocompromised, or had a positive urine culture result at index uUTI. In multivariable analyses, characteristics associated with rUTI included younger or older age (48-57 vs 18-27 years: adjusted risk ratio [aRR], 0.83 [95% CI, .80-.85]; ≥78 vs 18-27 years: aRR, 1.07 [95% CI, 1.03-1.11]), Charlson Comorbidity Index (≥3 vs 0: aRR, 1.12 [95% CI, 1.08-1.17]), and diabetes mellitus (aRR, 1.07 [95% CI, 1.04-1.10]). More frequent prior-year outpatient and emergency department encounters, oral antibiotic and oral contraceptive prescriptions, positive culture result at index uUTI, and antibiotic-resistant organisms were also associated with increased risk of rUTI.

CONCLUSIONS

The high risk of rUTI among women with cystitis is concerning, especially given previous reports of increasing UTI incidence. Current assessment of the epidemiology of rUTI may guide the development of preventive interventions against UTI.

摘要

背景

尿路感染(UTI)很常见,且常反复发作。然而,目前关于复发性 UTI(rUTI)的流行病学数据很少。

方法

2016 年 1 月 1 日至 2020 年 12 月 31 日,从 Kaiser Permanente Southern California 的女性电子健康记录中确定了门诊、急诊、医院和虚拟护理环境中的单纯性膀胱炎指数 UTI(uUTI)的指数病例。我们将 rUTI 定义为在 365 天内发生≥3 次 UTI 或在 180 天内发生≥2 次 UTI。我们确定膀胱炎指数 uUTI 女性中 rUTI 的比例,并使用修正后的多变量泊松回归分析确定与 rUTI 相关的因素。

结果

在 374171 名患有膀胱炎指数 uUTI 的女性中,54318 名(14.5%)患有 rUTI。与无 rUTI 的女性相比,rUTI 女性在指数 uUTI 时的年龄为 18-27 岁或≥78 岁的比例更高(19.7%比 18.7%和 9.0%比 6.0%),免疫功能低下,或指数 uUTI 时尿液培养阳性。多变量分析显示,与 rUTI 相关的特征包括年龄较小或较大(48-57 岁比 18-27 岁:调整后的风险比 [aRR],0.83 [95%CI,0.80-0.85];≥78 岁比 18-27 岁:aRR,1.07 [95%CI,1.03-1.11])、Charlson 合并症指数(≥3 分比 0 分:aRR,1.12 [95%CI,1.08-1.17])和糖尿病(aRR,1.07 [95%CI,1.04-1.10])。既往年度门诊和急诊就诊次数增加、口服抗生素和口服避孕药处方、指数 uUTI 培养阳性、以及抗生素耐药菌也与 rUTI 风险增加相关。

结论

膀胱炎女性 rUTI 的高风险令人担忧,尤其是考虑到之前 UTI 发病率增加的报告。目前对 rUTI 流行病学的评估可能有助于制定预防 UTI 的干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790f/11566237/dd4d4aa40427/jiae331f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790f/11566237/43e889193a62/jiae331f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790f/11566237/f42e55a499ff/jiae331f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790f/11566237/dd4d4aa40427/jiae331f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790f/11566237/43e889193a62/jiae331f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790f/11566237/f42e55a499ff/jiae331f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/790f/11566237/dd4d4aa40427/jiae331f3.jpg

相似文献

1
Risk Factors for Recurrent Urinary Tract Infections Among Women in a Large Integrated Health Care Organization in the United States.美国大型综合医疗机构中女性复发性尿路感染的危险因素。
J Infect Dis. 2024 Nov 15;230(5):e1101-e1111. doi: 10.1093/infdis/jiae331.
2
Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.大肠杆菌引起复发性尿路感染的重要细菌特征。
Dan Med Bull. 2011 Apr;58(4):B4187.
3
Economic burden of antibiotic-not-susceptible isolates in uncomplicated urinary tract infection: Analysis of a US integrated delivery network database.在单纯性尿路感染中,对抗生素不敏感的分离株的经济负担:美国综合交付网络数据库分析。
Antimicrob Resist Infect Control. 2022 Jun 14;11(1):84. doi: 10.1186/s13756-022-01121-y.
4
Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among patients with uncomplicated urinary tract infection: an analysis of integrated delivery network electronic health records.未优化或不适当治疗对单纯性尿路感染患者医疗资源利用和成本的影响:集成交付网络电子健康记录分析。
Antimicrob Resist Infect Control. 2022 Nov 4;11(1):133. doi: 10.1186/s13756-022-01170-3.
5
Obesity and recurrent urinary tract infections in premenopausal women: a retrospective study.绝经前女性肥胖与复发性尿路感染:一项回顾性研究。
Int J Infect Dis. 2015 Dec;41:32-5. doi: 10.1016/j.ijid.2015.10.014. Epub 2015 Oct 27.
6
Outpatient Urinary Tract Infections in an Era of Virtual Healthcare: Trends From 2008 to 2017.虚拟医疗时代的门诊下尿路感染:2008 年至 2017 年的趋势。
Clin Infect Dis. 2020 Jun 24;71(1):100-108. doi: 10.1093/cid/ciz764.
7
Sporadic compared to recurrent urinary tract infections: Considerations for urogynecologic patients.与复发性尿路感染相比:尿失禁患者的注意事项。
Neurourol Urodyn. 2020 Nov;39(8):2186-2191. doi: 10.1002/nau.24471. Epub 2020 Aug 17.
8
Assessment and Acquisition of Knowledge Regarding Urinary Tract Infection Among Adult Women in the United States.美国成年女性对尿路感染的认知评估与获取
Urology. 2024 Jul;189:34-40. doi: 10.1016/j.urology.2024.05.018. Epub 2024 May 23.
9
Antibiotic Resistance of Urinary Tract Infection Recurrences in a Large Integrated US Healthcare System.美国大型综合医疗系统中尿路感染复发的抗生素耐药性
J Infect Dis. 2024 Dec 16;230(6):e1344-e1354. doi: 10.1093/infdis/jiae233.
10
Baseline Characteristics, Evaluation, and Management of Women With Complaints of Recurrent Urinary Tract Infections.女性复发性尿路感染患者的基线特征、评估和管理。
Female Pelvic Med Reconstr Surg. 2021 May 1;27(5):275-280. doi: 10.1097/SPV.0000000000001065.

引用本文的文献

1
CAUTIon - not all UTIs are the same.注意——并非所有尿路感染都是相同的。
Nat Rev Urol. 2025 Aug 1. doi: 10.1038/s41585-025-01065-z.
2
Urinary tract infections in immunocompromised patients.免疫功能低下患者的尿路感染
Curr Opin Infect Dis. 2025 Aug 1;38(4):322-328. doi: 10.1097/QCO.0000000000001121. Epub 2025 Jun 9.
3
Comparative Assessment of Lower Urinary Tract Infections in Hospitalized Adults from Western Romania: A Retrospective Cohort with Microbiological Analysis.罗马尼亚西部住院成人下尿路感染的比较评估:一项微生物学分析的回顾性队列研究

本文引用的文献

1
Urinary Tract Infections in Pregnant Individuals.孕妇尿路感染。
Obstet Gynecol. 2023 Aug 1;142(2):435-445. doi: 10.1097/AOG.0000000000005269.
2
Diabetes downregulates the antimicrobial peptide psoriasin and increases E. coli burden in the urinary bladder.糖尿病下调抗菌肽 psoriasin 并增加大肠杆菌在膀胱中的负担。
Nat Commun. 2022 Sep 20;13(1):4983. doi: 10.1038/s41467-022-32636-y.
3
Immunocompromise and durability of BNT162b2 vaccine against severe outcomes due to omicron and delta variants.BNT162b2疫苗在免疫功能低下人群中针对奥密克戎和德尔塔变异株所致严重后果的有效性和持久性
Microorganisms. 2025 May 14;13(5):1130. doi: 10.3390/microorganisms13051130.
4
Incidence of extended spectrum beta-lactamase (ESBL) producing isolated from women with urinary tract infections in Jordan.从约旦患有尿路感染的女性中分离出的产超广谱β-内酰胺酶(ESBL)菌株的发生率。
Iran J Microbiol. 2025 Feb;17(1):41-50. doi: 10.18502/ijm.v17i1.17800.
5
Summary of guidelines from the Polish Urological Association, Polish Society of Gynaecologists and Obstetricians, and Polish Society of Family Medicine on the diagnosis, therapy, and management of community-acquired lower urinary tract infections.波兰泌尿外科学会、波兰妇产科医师学会和波兰家庭医学学会关于社区获得性下尿路感染的诊断、治疗及管理的指南摘要
Cent European J Urol. 2024;77(3):520-527. doi: 10.5173/ceju.2024.01.Guid. Epub 2024 Oct 29.
6
Comparison of phenotypic and genetic traits of ESBL-producing UPEC strains causing recurrent or single episode UTI in postmenopausal women.引起绝经后女性复发性或单次发作性泌尿道感染的产超广谱β-内酰胺酶(ESBL)的尿道致病性大肠杆菌(UPEC)菌株的表型和遗传特征比较。
Ann Clin Microbiol Antimicrob. 2025 Feb 7;24(1):11. doi: 10.1186/s12941-025-00779-7.
7
Prevalence of Antimicrobial Resistance Among the WHO's AWaRe Classified Antibiotics Used to Treat Urinary Tract Infections in Diabetic Women.用于治疗糖尿病女性尿路感染的世界卫生组织(WHO)按AWaRe分类的抗生素中的耐药性流行情况。
Antibiotics (Basel). 2024 Dec 14;13(12):1218. doi: 10.3390/antibiotics13121218.
Lancet Respir Med. 2022 Jul;10(7):e61-e62. doi: 10.1016/S2213-2600(22)00170-9. Epub 2022 May 6.
4
Longitudinal multi-omics analyses link gut microbiome dysbiosis with recurrent urinary tract infections in women.纵向多组学分析将肠道微生物失调与女性复发性尿路感染联系起来。
Nat Microbiol. 2022 May;7(5):630-639. doi: 10.1038/s41564-022-01107-x. Epub 2022 May 2.
5
The role of vaccines in combatting antimicrobial resistance.疫苗在对抗抗微生物药物耐药性中的作用。
Nat Rev Microbiol. 2021 May;19(5):287-302. doi: 10.1038/s41579-020-00506-3. Epub 2021 Feb 4.
6
Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms.隐匿于众目睽睽之下——重新审视临床算法中种族校正的应用
N Engl J Med. 2020 Aug 27;383(9):874-882. doi: 10.1056/NEJMms2004740. Epub 2020 Jun 17.
7
Outpatient Urinary Tract Infections in an Era of Virtual Healthcare: Trends From 2008 to 2017.虚拟医疗时代的门诊下尿路感染:2008 年至 2017 年的趋势。
Clin Infect Dis. 2020 Jun 24;71(1):100-108. doi: 10.1093/cid/ciz764.
8
Definition of Recurrent Urinary Tract Infections in Women: Which One to Adopt?女性复发性尿路感染的定义:应采用哪一种?
Female Pelvic Med Reconstr Surg. 2018 Nov/Dec;24(6):424-429. doi: 10.1097/SPV.0000000000000509.
9
The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998-2011.1998 - 2011年美国尿路感染住院人数的增加及相关费用
Open Forum Infect Dis. 2017 Feb 24;4(1):ofw281. doi: 10.1093/ofid/ofw281. eCollection 2017 Winter.
10
The Vaginal Microbiota and Urinary Tract Infection.阴道微生物群与尿路感染。
Microbiol Spectr. 2016 Dec;4(6). doi: 10.1128/microbiolspec.UTI-0025-2016.